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BACKGROUND: Uric acid is a final result of purine catabolism, the enzymatic reactions in the body cells from amino acids or ribonucleotide dinucleotide. 
Peperomia pellucida L. (P. pellucida), Acalypha indica L. 
(A. indica) and Momordica charantia L. (M. charantia)  are 
plants  which  have  efficacy  to  reduce  levels  of  uric  acid 
excess. The aim of this research is to find out the effect of 
ethanol extract of P. pellucida, A. indica and M. charantia 
in preventing the formation of uric acid excess by inhibiting 
the action of the enzyme xanthine oxidase and comparing 
the inhibition activity of xanthine oxidase on treatments.  
METHODS: The study design is experimental and 
conducted using the enzyme xanthine oxidase, xanthine 
(substrate), pH 7.5 phosphate buffer, samples (P. pellucida, 
A. indica  and  M. charantia  ethanol  extracts)  and  HCL 
as reaction breaker. Inhibition of xanthine oxidase was 
determined enzymatically and unreacted xanthine was 
measured by UV spectrophotometer at 290 nm. The data 
were expressed as percent inhibition and the inhibitory 
concentration (IC)50 were determined using linear regresion 
of inhibition activity vs. concentration.
RESULTS:   The   IC50   of   P.  pellucida,   A.  indica   and 
M. charantia ethanol extracts in inhibiting xanthine oxidase 
were 19.5 ppm, 77.6 ppm and 17.8 ppm, respectively. 
IC50 of allopurinol was 1.99 µg/ml, and negative control 
(combination of enzyme and substrate) has absorbance 
value of 0.75026.
CONCLUSION: Ethanol extract of M. charantia showed 
the most potent inhibition toward xanthine oxidase 
compared to the other two extracts. 
KEYWORDS: xanthine oxidase, Peperomia pellucida L., 
Acalypha indica L., Momordica charantia L.
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Abstract
Introduction
Uric acid is a final result of catabolism purines, the 
enzymatic reactions in the body cells from amino acids 
or ribonucleotide dinucleotide.(1,2) The occurance of 
hyperuricaemia, or excessive increase of uric acid in the 
blood, will cause gout disease.(3,4) Xanthine catalyzed by 
the enzyme xanthine oxidase will form uric acid. Xanthine 
oxidase,  which  plays  an  important  role  in  the  purines 
catabolism, is found in liver and muscle cells, but can not be 
found in the blood.(5) The normal value of uric acid level 
is  3.5  to 7.0  mg/dL  for  man  and  2.5  to 6.0  mg/dL  for 
women.
162
The Indonesian Biomedical Journal, Vol.8, No.3, December 2016, p.161-6 Print ISSN: 2085-3297, Online ISSN: 2355-9179
 The intake of foods containing high purines will 
increase uric acid levels. The use of Peperomia pellucida 
L. (P. pellucida), Acalypha indica L. (A. indica) and 
Momordica charantia L. (M. charantia) in lowering uric acid 
levels is very beneficial. Purine and pyrimidine nucleotides 
synthesized in vivo at a pace that is consistent with 
physiological needs. The purine bases are then oxidized to 
uric acid, which may be absorbed and excreted in the urine. 
While little or no dietary purine or pyrimidine is incorporated 
into tissue nucleic acids. There are three processes that 
have roles in the biosynthesis of purine nucleotides. These 
three processes, sorted from the most important, are the 
synthesis of intermediates amphibolic (synthesis de novo), 
phosphorylation of purine and  phosphorylation  of  purine 
nucleoside.
 Adenosine  first undergo deamination into inosine by 
the help of adenosine deaminase enzyme.(6) Hypoxanthine 
and xanthine guanine subsequently formed in a reaction 
catalyzed by enzyme xanthine oxidase and guanase, 
respectively. The oxidized xanthine is turned into uric 
acid in the second reaction catalyzed by the enzyme 
xanthine oxidase. Thus, xanthine oxidase is an essential 
place for pharmacological intervention  in  patients  with 
hyperuricemia  and  gout.(7,8)
 These days, many number of plants have been proved 
empirically or by scientific testing and used as alternative 
treatments.(9)  Some  plants  have  been  proved to be 
effective in lowering the level of uric acid excess, those are 
P. pellucida, A. indica and M. charantia. 
 Other efficacy  of  P. pellucida  is  its  ability  to  cope 
with headache, abdominal  pain,  abscesses,  ulcers,  kidney 
disorders,  acne,  dermatitis,   minor  burns   and   pain 
in   rheumatoid  arthritis.(10,11) Extract of P. pellucida 1g/
kg bw/day in rats induced potassium oxonate three hours 
before treatment, suggesting that P. pellucida can be used as 
an alternative medicine for uric acid.(12) 
 Beside it effects as an anti-uric acid, A. indica also 
has efficacy as an anti-inflammatory, diuretic, laxative and 
hemostasis. Extract of A. indica 2.7g/200g bw/day can 
effectively lower uric acid level in rats, which induced 
potassium oxonate one hour before treatment.(13) 
 Another plant that is often used in the treatment of uric 
acid is M. charantia.(14) Therefore, this study  was  done 
to find out  the  ethanol  effects  of  extract P. pellucida,  A. 
indica  and  M. charantia in inhibition of the formation uric 
acid by using the in vitro treatment method.
Methods
The design of this study was experimental study with post-
test group design, using the three treatment groups with 
each repetition three times. For the manufacture of blanks 
solution, 2.8 mL of potassium  phosphate  buffer  pH  7.5 
was  inserted  then  0.1  mL  of  xanthine  was  added. For 
control sample (allopurinol), 2.9 mL potassium phosphate 
buffer at pH 7.5 and 0.1 of mL sample were inserted. 
Meanwhile for the negative control, 2.7 mL of potassium 
phosphate buffer pH 7.5, 0.1 mL xanthine and 0.1 mL 
xanthine oxidase were inserted. As for the samples, 2.6 mL 
of potassium phosphate buffer at pH 7.5, 0.1 xanthine, 0.1 
mL xanthine oxidase and 0.1 mL of sample were inserted. 
After all solution inserted in to the cuvette, it was incubated 
for 10 minutes. After the incubation, 0.1 mL of HCl was 
added as the breaker of enzyme  reaction. The absorbance 
measurement is performed using a spectrophotometer at a 
wavelength of 290 nm.
 Materials used were botanicals P. pellucida, A. indica 
and M. charantia which were obtained in Makassar, distilled 
water, 96% ethanol, DMSO, K2HPO4.3H2O, KH2PO4.3H2O, 
NaOH, HCl, allopurinol, xanthine and xanthine oxidase 
(Sigma, St. Louis, USA). The preparation of  P.pellucida, 
A. indica and M. charantia  was  performed  at  the  Biology 
Laboratory  of Halu Oleo University. Those plants were 
harvested, sorted and then cut into pieces. Lastly they were 
dried and then stored in airtight plastic bags until being 
used.
Preparation of Extract
Initially, the herbs were cleaned, washed with water, and cut 
into small pieces. After it was dried, then it was placed in an 
open space with good circulation and no exposure to direct 
sunlight. It could not be placed in high temperature because 
the exposure of direct sunlight causes damage to the active 
component in herbs. 
 The dried  herbs then  extracted by maceration 
method, which was soaking the dried herbs in a solvent of 
ethanol 96% for 24 hours, then filtered it with filter cloth 
and soaked it in ethanol 96% until it was extracted perfectly. 
After  that, the solvent is evaporated on a rotary evaporator 
and the remaining ethanol aerated to obtain a thick extract 
with a concentration of 100%.
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Preparation of Potassium Phosphate Buffer pH 7.5
Potassium phosphate buffer at pH 7.5 was manufactured 
at  25°C,  by  mixing  0.68045  g  of  KH2PO4.3H2O  and 
4.352 g of K2HPO4.3H2O, which was dissolved in 500 mL 
of deionized aqua.
Making Xanthine 0:15 mM
The substrate was created by dissolving 22.5 mg of xanthine 
using 10 mL phosphate buffer from previous solution. Then 
the substrate was sufficed by taking 1 mL to 100 mL.
Xanthine Oxidase Inhibition Test in Vitro
Power  test  inhibition  of  ethanol  extract  P. pellucida, 
A. indica and M. charantia was performed at the optimum 
condition which refers to the Sigma product sheet. That 
optimum condition refers to a 10 minutes incubation time 
at the temperature of 25°C, pH 7.5, a wavelength 290 nm, 
xanthine oxidase concentration of 0.1 unit/mL  and  xanthine 
concentration of  0.15 mM. 
 Total of 2.6 mL phosphate buffer was  put  in  a  test 
tube,  followed  by 0.1 mL  extract. Then 0.1 mL of 0.15 
mM xanthine and 0.1 mL of  0.1  unit/mL xanthine oxidase 
added to the mixture, and incubated at a temperature of 
25°C for 10 minutes. 
 After the incubation, the mixture was immediately 
added by 0.1 mL of 1 M HCl to stop the reaction. The 
mixture was measured using UV absorption at a wavelength 
of 290 nm to see how big the rest of xanthine unreacted in 
the test sample. The obtained power inhibition test result 
was compared to allopurinol result.
Table 1 shows the result of xanthine oxidase inhibitory 
activity  of  the  ethanol  extract  of  P. pellucida,  A. indica, 
M. charantia and allopurinol (as positive control). It shows 
the concentration, log concentration, inhibition percentage, 
probit and inhibitory concentration (IC)50 value from 
each sample extract and the positive control. IC50 values 
from each extract are obtained to determine the effect 
and comparison  of enzyme  xanthine  oxidase  inhibitory 
activity. IC50 values were 19.5 µg/mL, 77.6 µg/mL, 17.8 µg/
mL and 1.9 µg/mL for P. pellucida, A. indica, M.charantia 
and allopurinol, respectively. 
Results
Plants used in this research are P. pellucida, A. indica and 
M. charantia which were extracted by maceration method. 
Maceration process was done by soaking the sample in a 
container using liquid  extraction  of  96%  ethanol  for 
3x24 hours with occasional stirring, then being filtered. 
During the soaking, extraction liquid would penetrate the 
cell wall and enter the cell. Maceration method was chosen 
to avoid damage  because  the  chemical  constituents  are 
not  resistant to  heating  and  provide  good result and 
selectively extracted.
 The  primary  data  of  xanthine  oxidase  inhibition 
assay results was obtained from the treatment group and 
a control group in Hasanuddin University Pharmaceutical 
Chemistry    Laboratory.   The   test   sample   consisted   of 
P. pellucida, A. indica and M. charantia ethanol extract, 
as well as the positive control which was allopurinol and 
negative controls which was combination of enzyme and 
substrate. Data were analyzed to determine the percentage 
of  inhibition  values,  followed  by  linear  regression 
statistical test and the determination of the inhibitory 
activity of enzyme xanthine oxidase samples to determine 
the IC50 value.
 Purine bases converted into hypoxanthine by xanthine 
oxidase are converted into xanthine and uric acid. Uric acid 
is formed and then discharged through urine, gastrointestinal 
tract and partially backfilled in tissue in the form of 
monosodium uric (MSU) crystals, which over time will 
accumulate and form microtophy. While the inflammatory 
process  that  occurs  due  to  the  deposition  of  uric  acid 
crystals in the tissues around the joints, gout is also a term 
used for a group of metabolic disorders characterized 
by an increased concentration of uric acid, or also called 
hyperuricemia. 
 Enzymes can not work without the substrate, so does 
enzyme  xanthine  oxidase  that will  only  work on an 
appropriate  substrate,  which  is  xanthine. 
 Xanthine oxidase  catalyzes xanthine by addition of 
distilled water and  oxygen  into  uric  acid  and  hydrogen 
peroxide.  Hydrogen peroxide  has  the ability to  diffuse 
into  and penetrate  the cell membrane   that  can  cause 
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Table 1. Determination of inhibition percentage and IC50.
Sample Concentration (ppm) Log Concentration 
Inhibition 
Percentage (%) Probit IC50 (µg/ml)
200 2.3 21.01 4.19
100 2.0 35.53 4.62
50 1.7 43.86 4.84
25 1.4 48.61 4.96
12.5 1.1 50.44 5.01
200 2.3 60.75 5.27
100 2.0 50.52 5.01
50 1.7 46.76 4.91
25 1.4 40.86 4.77
12.5 1.1 29.31 4.46
6.25 0.8 7.03 3.52
100 2.0 23.99 4.29
50 1.7 42.44 4.81
25 1.4 47.32 4.93
12.5 1.1 52.58 5.07
6.25 0.8 63.56 5.35
5 0.7 39.55 4.74
2.5 0.4 45.04 4.87
1.25 0.1 51.75 5.04
0.625 -0.2 67.98 5.47
0.3125 -0.5 77.28 5.75
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 Measurement of xanthine oxidase inhibitory activity 
was performed according to the Bergmeyer “Method 
in Enzymology”. The samples were measured using 
spectrophotometer based on the decrease in absorption at 
290 nm. Measurement of the activity of xanthine oxidase 
was  done  at  pH 7.5,  because  if  the  atmosphere  is too 
acidic  or  alkaline,  it  can  cause  loss  of  xanthine  oxidase 
activity.
 In vitro  testing  was  conducted to  observe  the 
activity of the enzyme xanthine oxidase on the formation 
of  urate  crystals.  A  decrease  in  the  activity  of  xanthine 
oxidase  in the ethanol extract of P. pellucida, A. indica 
and M. charantia will reduce or prevent the formation of 
urate crystal and hydrogen peroxide. This  test was done to 
determine the extent of the effects that have been caused by 
the extracts.
 Testing IC50 previously used to extract samples 
contained some activity, P. pellucida extracts showed 
antioxidant activity (15), inhibitory effects on three cancer 
cell lines and has a weak suppressor activity in HL-60 cells 
(16). The methanol extract of A. indica, showed anticancer 
activity against cell-NCIH187 small lung cancer, showed 
significant anticancer activity against HT-29 colon cancer 
cells (17), and the test protein denaturation, 37 mg/mL 
in action proteinase inhibitory and 18 mg/mL for anti-
hyaluronidase activity (18). As well as the methanol extract 
of M. charantia, dose-dependent inhibit the activity of 
sucrase most powerful of the intestinal mucosa (19), and 
has disaccharidase-inhibitory activity on the improvement 
of blood glucose and serum (20).
 Each extract was tested in the same concentration, 
which was 60 mg. After determining the concentration, 
measurement of absorbance obtained from each 
concentration is the value to be incorporated into the linear 
regression equation to obtain IC50 value.
 The information of IC50 value in this research is aimed 
to determine the effect and comparison enzyme xanthine 
oxidase  inhibitory  activity  of  the  test  sample. It was 
obtained ethanol extract of P. pellucida  IC50 = 19.5 µg/
mL, the ethanol extract of A. indica IC5 0= 77.6 µg/mL, 
the ethanol  extract of M.charantia IC50 = 17.8 µg/mL, 
allopurinol (positive control) IC50 = 1.99 µg/mL and the 
negative controls (combination of enzyme and substrate) 
has absorbance value of 0,75026. IC50 value was inversely 
related to the inhibition of xanthine oxidase activity, the 
smaller the  IC50  value, the greater the inhibition activity of 
xanthine oxidase (Table 1).
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